Acadia Pharmaceuticals had to defend its Nuplazid safety last year, and now the drugmaker faces a different type of scrutiny: A Justice Department investigation into its marketing practices.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,